364 related articles for article (PubMed ID: 31410193)
1. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
Calsina B; Castro-Vega LJ; Torres-Pérez R; Inglada-Pérez L; Currás-Freixes M; Roldán-Romero JM; Mancikova V; Letón R; Remacha L; Santos M; Burnichon N; Lussey-Lepoutre C; Rapizzi E; Graña O; Álvarez-Escolá C; de Cubas AA; Lanillos J; Cordero-Barreal A; Martínez-Montes ÁM; Bellucci A; Amar L; Fernandes-Rosa FL; Calatayud M; Aller J; Lamas C; Sastre-Marcos J; Canu L; Korpershoek E; Timmers HJ; Lenders JW; Beuschlein F; Fassnacht-Capeller M; Eisenhofer G; Mannelli M; Al-Shahrour F; Favier J; Rodríguez-Antona C; Cascón A; Montero-Conde C; Gimenez-Roqueplo AP; Robledo M
Theranostics; 2019; 9(17):4946-4958. PubMed ID: 31410193
[No Abstract] [Full Text] [Related]
2. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
3. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
4. [MicroRNA differential expression profile in tuberous sclerosis complex cell line TSC2
Cai Y; Guo H; Li HZ; Wang WD; Zhang YS
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):580-584. PubMed ID: 28816269
[TBL] [Abstract][Full Text] [Related]
5. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
[TBL] [Abstract][Full Text] [Related]
6. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
7. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
11. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers.
de Cubas AA; Korpershoek E; Inglada-Pérez L; Letouzé E; Currás-Freixes M; Fernández AF; Comino-Méndez I; Schiavi F; Mancikova V; Eisenhofer G; Mannelli M; Opocher G; Timmers H; Beuschlein F; de Krijger R; Cascon A; Rodríguez-Antona C; Fraga MF; Favier J; Gimenez-Roqueplo AP; Robledo M
Clin Cancer Res; 2015 Jul; 21(13):3020-30. PubMed ID: 25825477
[TBL] [Abstract][Full Text] [Related]
15. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
16. A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer.
Poel D; Gootjes EC; Bakkerus L; Trypsteen W; Dekker H; van der Vliet HJ; van Grieken NCT; Verhoef C; Buffart TE; Verheul HMW
Cancer Med; 2020 Oct; 9(20):7558-7571. PubMed ID: 32864858
[TBL] [Abstract][Full Text] [Related]
17. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
18. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
19. Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications.
Trelinska J; Fendler W; Dachowska I; Kotulska K; Jozwiak S; Antosik K; Gnys P; Borowiec M; Mlynarski W
Orphanet J Rare Dis; 2016 Sep; 11(1):129. PubMed ID: 27680012
[TBL] [Abstract][Full Text] [Related]
20. MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.
Pu Y; Zhao F; Cai W; Meng X; Li Y; Cai S
Clin Exp Metastasis; 2016 Apr; 33(4):359-72. PubMed ID: 26913720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
